Search
Search
Contact Lawson Research Institute
Contact us
For general information or Lawson-specific questions:
Phone: 519 646-6005
Email: @email
To reach a member of the Lawson/St. Joseph’s Communications team with a story idea or a media-related inquiry, contact:
Communication and Public Affairs
Phone: 519 646-6100 ext. 66034
Fax: 519 646-6215
Email: comdept@sjhc.london.on.ca
If you need to contact a communicator after office hours (Mon to Fri, 8:30 am to 4:30 pm), call Switchboard at 519 646-6100 and ask them to page the communicator on-call.
Directions and parking
The main office of Lawson Research Institute is located within St. Joseph's Hospital. You can find a map to St. Joseph's Hospital along with Parking information below.
Lawson Research Institute inside St. Joseph's Hospital
268 Grosvenor Street
London, Ontario, N6A 4V2
Parking options
For those planning to park at or near St. Joseph’s Hospital, please ensure you leave extra time to do so. Due to the high number of people coming for care at St. Joseph’s Hospital, our two parking garages located on Grosvenor Street and on Cheapside Street are often at capacity Monday to Thursday between 9:30 a.m. and 2 p.m. ‘Lot full’ signs are posted when the parking garage(s) are full. Metered parking is available on the streets around the hospital.
As parking availability isn’t guaranteed at or nearby the hospital, St. Joseph’s encourages patients and family caregivers to consider making alternate travel arrangements when coming to the hospital, such as using public transit, taxi or being dropped off and picked up. Drop off areas are available at Entrance 1 and 2 on Grosvenor Street and Entrance 4 on Cheapside Street.
St. Joseph’s recognizes the frustration the lack of parking availability may cause and apologizes for any inconvenience. Thank you for your patience and understanding while we seek solutions to this issue.
Grosvenor parking garage
Daily rate: Minimum rate of $4 for the first hour and then $2 increments every half hour to a maximum of $8.75 after 2 hours.
Monthly rate: $60.75
There are 989 parking spaces in the Grosvenor Street parking garage.
View a printable map of parking spaces at St. Joseph's Hospital, Grosvenor Street Parking Garage (including accessible spaces).
The parking garage entrance is located on Grosvenor Street, across the street from Grosvenor Entrance 1. The garage is connected to Mount Hope Centre for Long Term Care through the underground tunnel (take elevators at northwest corner of the garage, see below).
Tunnel access at St. Joseph's Hospital
When visiting St. Joseph's Hospital and parking in the parking garage on Grosvenor Street the safest and most accessible route is through the tunnel. You can access the tunnel from the west end of the parking garage (closest to Richmond Street) by taking the elevators or stairs to level "B". When returning to your vehicle from Zone A you will need to push "T" (for tunnel) in the elevator.
Parking pay stations
Parking pay stations are located on the ground floor of both elevator lobbies located at the north-west and north-centre area of garage.
Pay stations only accept coins and credit cards. To purchase a monthly pass visit the Parking Garage office on the Wellington Street side of the Grosvenor Street Parking Garage, ground floor.
For further information, please call the parking office at 519 646-6100 ext. 65113.
Parking office hours are 8 am to 4 pm, Monday to Friday. Outside those hours, calls are directed to Precise ParkLink Inc. at 1-888-783 PARK (7275). The call centre can also be reached by intercom available on the parking pay machines in the garage's elevator lobby.
Accessible parking spaces
Accessible parking is available on each floor of the Grosvenor Street parking garage at the west end of the garage (closest to the Richmond and Grosvenor Street corner.) These parking spots are located close to the elevator that will take you to the wheelchair-accessible ramp on street level (level 1) or the underground tunnel that connects to both Mount Hope Centre for Long Term Care and St. Joseph’s Hospital.
Limited spots for accessible parking is also available on Wellington Street and on Grosvenor Street across from the Urgent Care Centre entrance (Entrance 2).
Cheapside parking garage
There are 132 parking spaces in the Cheapside Street parking garage.
View a printable map to parking spaces at St. Joseph's Hospital, Cheapside Street Parking Garage (including accessible spaces).
This is the closest lot for outpatients with appointments in Zones C and D of the hospital (Medical Imaging, Roth McFarlane Hand and Upper Limb Centre, Hand Therapy, Breast Care Centre, Rheumatology Centre, Physiotherapy Therapy, Occupational Therapy, WSIB Specialty Clinic, Shuttleworth Auditorium).
The entrance to the lot is on Cheapside Street just east of Richmond. It is open from 5:30 am to 5:30 pm, Monday to Friday, and closed on weekends. The elevator in the garage connects directly with the Francis and Madeleine Saul Medical Imaging Centre (Level 0) and the G. A. Huot Surgical Centre (Level 1). For appointments in Zone D, exit the parking garage elevator on Level 0 and walk across the lobby to the west side.
The parking pay station is located by the main elevators next to the gift shop in the Zone C lobby.
Parking meters at St. Joseph's Hospital
There are many city parking meters located within walking distance to St. Joseph's Hospital.
Rates are posted on the meters.
Street parking at St. Joseph's Hospital
Some of the residential streets that are within walking distance to the health centre offer one or two hour parking. Overnight parking is not permitted.
Please be courteous and do not block driveways.
Courteous parking to ensure maximum lot capacity
Please be aware that the City of London enforces parking regulations across all of St. Joseph’s sites to ensure patients, visitors, staff and physicians have adequate parking. All users of our parking facilities are asked to pay attention to parking regulations and how you park your vehicle.
As well, those who park for more than 10 minutes in patient drop-off designated areas, in handicapped parking without a permit, at loading docks, and other restricted areas will also find their vehicles being ticketed.
Thank you for respecting our parking regulations. If you have any parking questions please contact Precise ParkLink Inc.
Email: @email
Phone: 1-888-783 PARK (7275)
Public transit to St. Joseph's Hospital
St. Joseph's Hospital is conveniently located in a central location, with easy access to public transportation. Bus stops are located along Richmond Street and close to the Cheapside Street entrances. Contact the London Transit Commission at 519 451-1347 for rates and times.
The following London Transit bus routes will drop you off near entrances to St. Joseph's, see the London Transit trip planner and route schedules and real time LTC bus route tracking for more information:
- 6 Richmond
- 13 Wellington
- 1 Kipps Lane
- 21 Huron Heights
St. Joseph's is also just a few blocks north of Oxford Street, providing easy access from the Oxford St. bus routes.
First Contrast Enhanced Spectral Mammography (CESM) guided biopsy in North America
LONDON, ON – Researchers at Lawson Health Research Institute (Lawson) are the first in North America to perform a breast biopsy guided by Contrast Enhanced Spectral Mammography (CESM).
CESM is a novel diagnostic imaging tool that is able to detect cancerous lesions at a greater rate than standard mammography, and at close rate to MRI. Patients who undergo CESM receive an intravenous iodinated contrast liquid. This liquid acts as a dye that enhances the visibility of certain tissues during a radiographic imaging procedure, such as mammography or x-ray.
Currently, when a suspicious lesion is detected by CESM and not detected by standard mammography or ultrasound, the patient must return later for an MRI biopsy. Wait times for MRI can be lengthy, and the procedure itself is often long and uncomfortable.
CESM guided biopsy offers the ability to perform biopsy of the lesion of concern using mammography, after iodinated contrast injection. The procedure is faster and more accurate, comfortable and cost effective than an MRI biopsy.
The first CESM guided biopsy in North America was performed on June 12, 2020, at St. Joseph’s Health Care London (St. Joseph’s). Dr. Anat Kornecki, Lawson Associate Scientist and Radiologist at St. Joseph’s explains, “this new approach has the potential to provide rapid and accurate access for patients and reduce costs. With CESM biopsy technology we are also able to perform biopsy of lesions that are located in areas that MRI guided biopsy cannot reach.”
“Our initial experience has been very successful, and we hope to see an impact on patient care as well as breast cancer outcomes,” says Dr. Kornecki.
The study will recruit 50 patients who have a suspect finding detected using CESM.
-30-
Lawson Health Research Institute is one of Canada’s top hospital-based research institutes, tackling the most pressing challenges in health care. As the research institute of London Health Sciences Centre and St. Joseph’s Health Care London, our innovation happens where care is delivered. Lawson research teams are at the leading-edge of science with the goal of improving health and the delivery of care for patients. Working in partnership with Western University, our researchers are encouraged to pursue their curiosity, collaborate often and share their discoveries widely. Research conducted through Lawson makes a difference in the lives of patients, families and communities around the world. To learn more, visit www.lawsonresearch.ca.
Senior Media Relations Consultant
Communications & Public Engagement
T: 519-685-8500 ext. 73502
Celine.zadorsky@lhsc.on.ca
First Contrast Enhanced Spectral Mammography guided biopsy in North America
Researchers at Lawson Health Research Institute (Lawson) performed the first breast biopsy guided by Contrast Enhanced Spectral Mammography (CESM) in North America on June 12, 2020.
CESM is a novel diagnostic imaging tool that is able to detect cancerous lesions at a greater rate than standard mammography, and at close rate to MRI. Patients who undergo CESM receive an intravenous iodinated contrast liquid. This liquid acts as a dye that enhances the visibility of certain tissues during a radiographic imaging procedure, such as mammography or x-ray.
Currently, when a suspicious lesion is detected by CESM and not detected by standard mammography or ultrasound, the patient must return later for an MRI biopsy. Wait times for MRI can be lengthy, and the procedure itself is often long and uncomfortable.
CESM guided biopsy offers the ability to perform biopsy of the lesion of concern using mammography, after iodinated contrast injection. The procedure is faster and more accurate, comfortable and cost effective than an MRI biopsy.
The study will recruit 50 patients who have a suspect finding detected using CESM.
Dr. Anat Kornecki, Lawson Associate Scientist and Radiologist at St. Joseph’s Health Care London explains, “this new approach has the potential to provide rapid and accurate access for patients and reduce costs. With CESM biopsy technology we are also able to perform biopsy of lesions that are located in areas that MRI guided biopsy cannot reach.”
“Our initial experience has been very successful, and we hope to see an impact on patient care as well as breast cancer outcomes,” says Dr. Kornecki.
Groundbreaking Alzheimer’s and cancer studies receive $7.2M boost
Lawson Research Institute scientists and partners will focus on molecular imaging and theranostics to potentially transform the detection and treatment of neurodegeneration and cancer.
The quest to advance detection and treatment of Alzheimer’s disease and to personalize cancer care has received a major boost, with $7.2 million in funding to Lawson Research Institute (Lawson) of St. Joseph’s Health Care London (St. Joseph’s) for first-of-its kind research.
Lawson scientists will partner with a broad team of researchers at London Health Sciences Centre Research Institute (LHSCRI), McMaster University, University Health Network and BC Cancer on the ground-breaking studies focused on molecular imaging and theranostics as a potential game-changer in detecting and treating neurodegeneration and cancer, particularly prostate, brain and breast cancer.
Principal investigator Ting-Yim Lee, PhD, Lawson’s Director of PET/CT Research, and his team of investigators were awarded $2 million through the Ontario Research Fund – Research Excellence for the study titled “Improving Cancer and Alzheimer’s Disease Diagnosis and Treatment Through Cutting-edge Molecular Imaging and Theranostics”. Co-Principal Investigator is radiation oncologist Dr. Glenn Bauman at LHSCRI.
Additional funding from private-sector partners and Lawson, as well as from donors through St. Joseph’s Health Care Foundation, brings the total research investment to $7.2 million.
The research has the potential to offer hope for solutions to some of the most prevalent and pernicious diseases affecting Canadians, explains Lee.
“Both research projects are the first of their kind in Canada aimed at advancing how we diagnose and treat Alzheimer’s disease and cancer,” he says. “This collaborative funding initiative will also drive innovation in the exciting field of molecular imaging and theranostics at St. Joseph’s, at the heart of which is St. Joseph’s new, high-sensitivity GE HealthCare Omni Legend 2 PET/CT – the first in Canada.”
The studies encompass the following:
- Alzheimer’s disease: The new PET/CT at St. Joseph’s allows researchers to simultaneously study both blood flow and glucose metabolism in the brain. Both these mechanisms are believed to be contributing factors in the onset of Alzheimer’s. By measuring both at the same time, the research team hopes to uncover early signs that the brain is in trouble and at risk of plaque deposits and toxic proteins that have been linked to the development of Alzheimer’s.
- Cancer: The cancer study will focus on developing theranostic techniques to achieve personalized dosimetry – a method used to determine the exact amount of radiation a patient should receive during treatment, based on their individual characteristics. This maximizes effective treatment while minimizing harm to healthy tissues.
Molecular imaging and theranostics is a rapidly emerging field of medicine that combines ultra-precise scans and theranostics (a term that melds the words therapeutics and diagnostics). Together, they offer a one-two punch by integrating imaging and radiotracers that can identify the location and extent of diseased tissues and selectively destroy the abnormal cells while leaving surrounding healthy cells undamaged. In collaboration with GE HealthCare, St. Joseph’s is developing Canada’s first GE HealthCare Centre of Excellence in Molecular Imaging and Theranostics.
“By bridging the gap between research and clinical practice, we hope to ease the burden on patients and their families, offering more effective and compassionate care”
-Ting-Yim Lee, PhD, Director of PET/CT Research at Lawson Research Institute.
“We are already seeing the impact of novel theranostics for treatment of men with advanced prostate cancer,” says Bauman. “Promising new theranostic approaches are emerging for many cancers and this investment further positions London to be a leader in this area of research.”
In the initial phase of the studies, 100 patients will be recruited from St. Joseph’s Aging Brain and Memory Clinic at Parkwood Institute for the Alzheimer’s study; while 90 patients will be recruited from London Health Sciences Centre’s Verspeeten Family Cancer Centre for cancer studies. There are plans to recruit patients from the collaborating centres once results from the initial phase are confirmed.
“By bridging the gap between research and clinical practice, we hope to ease the burden on patients and their families, offering more effective and compassionate care,” says Lee. “We are deeply grateful for the opportunity to turn our research into real-world solutions that can make a meaningful impact.”
With dozens of 'firsts' in imaging research, “Lawson is a powerhouse of innovation,” adds Michael Kovacs, PhD, Program Lead, Lawson’s Imaging Research Program, and Lead, Cyclotron & PET Radiochemistry Facility. “We're excited to explore how this work could transform care."
Lawson Impact Awards celebrates research making a difference
With nearly 300 guests in attendance, health research was celebrated at the fourth annual Lawson Impact Awards on Wednesday, April 19 at the London Convention Centre.
The Lawson Impact Awards celebrates hospital-based research that makes a difference by advancing scientific knowledge and applying it directly to patient care. With awards in seven categories, the annual event honours Lawson scientists, staff, trainees and partners who demonstrate excellence.
“The Lawson Impact Awards recognizes those who have made exceptional contributions to science and innovation. This year's winners include individuals, groups and partners who work tirelessly to improve our understanding of health and disease in Canada and around the world,” says Dr. David Hill, Scientific Director, Lawson Health Research Institute.
This year’s Lawson Impact Awards winners include:
- Dr. Peeyush Lala - Scientist Career Award
- Drs. Glenn Bauman and Aaron Ward - Innovation Award
- Dr. Gediminas Cepinskas - Dr. Joseph Gilbert Research Contribution of the Year Award
- IDB Holland bv - Industry Partner of the Year Award
- Helen and Andy Spriet - Community Partner of the Year Award
- Arthroplasty Clinical Research Team (Dr. Lyndsay Somerville, Codie Primeau and Bryn Zomar) - Staff Award of Excellence
- Charles Ishak - Leadership Award (Student & Trainee)
The recipients of Lawson’s 2017 Strategic Research Fund (SRF) were also revealed at the Lawson Impact Awards. The Lawson SRF is an annual competition that supports projects that will advance science in alignment with Lawson’s strategic research goals, as outlined in the Lawson Strategic Plan 2014-2018. For the second year in a row, the 2017 competition was focused on “inflammation”. The following two projects were awarded $50,000 over a two-year period:
- “Re-setting the breast microbiome to lower inflammation and risk of cancer” – Drs. Muriel Brackstone and Gregor Reid
- “Assessing acute cardiac inflammation after left-sided breast cancer radiotherapy with hybrid PET/MRI” – Drs. Stewart Gaede and Gerald Wisenberg
A highlight of the event was a keynote presentation from record-breaking Canadian astronaut, aquanaut and researcher, Dr. Dave Williams, titled “The Art of the Possible: Innovation Transforming Healthcare”. Dr. Williams provided an inspiring talk that used examples from his space shuttle missions and health research to illustrate how the impossible can be made possible.
In addition, this year’s event honoured Canada’s 150th year as a nation by paying tribute to Canadian scientists and the contributions they’ve made on the world stage. Acknowledging the role of Lawson scientists in continuing this legacy, attendees were also asked to provide their feedback about the future of innovation. These insightful ideas will be shared in the months to come as Lawson continues to celebrate Canada 150.
To view videos of each award winner, visit the Lawson YouTube page. To see more photos from the event, visit Lawson's Facebook page.